JP Morgan Chase’s Edesa Biotech EDSA Stock Holding History

JP Morgan Chase’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14	Closed	–	–	5388
2019 Q4	$0	Buy	+14	New	+$495	﹤0.01%	5662

Other funds holding EDSA

BBA

Braun-Bostich & Associates Canonsburg, Pennsylvania $179M AUM 21.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's EDSA Position: Q1 2020 in Review

JP Morgan Chase sold out of Edesa Biotech (EDSA) in Q1 2020, closing a stake of 14 shares.

JP Morgan Chase first reported a position in EDSA in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 8 funds tracked by Wall St. Rank hold EDSA as of Q1 2020.

JP Morgan Chase reported no remaining Edesa Biotech position as of Q1 2020 after selling out during the quarter.
JP Morgan Chase sold 14 Edesa Biotech shares in Q1 2020.
JP Morgan Chase first reported a position in Edesa Biotech in Q4 2019 and held it in 1 quarter.
JP Morgan Chase's Edesa Biotech position peaked at $0 in Q4 2019.
8 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2020.

Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.